company background image
4169 logo

TCM Biotech International TPEX:4169 Stock Report

Last Price

NT$58.20

Market Cap

NT$3.4b

7D

-1.0%

1Y

0.9%

Updated

22 Dec, 2024

Data

Company Financials +

TCM Biotech International Corp.

TPEX:4169 Stock Report

Market Cap: NT$3.4b

4169 Stock Overview

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. More details

4169 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

TCM Biotech International Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for TCM Biotech International
Historical stock prices
Current Share PriceNT$58.20
52 Week HighNT$63.60
52 Week LowNT$49.75
Beta0.094
1 Month Change-2.68%
3 Month Change-3.32%
1 Year Change0.87%
3 Year Change53.21%
5 Year Change169.46%
Change since IPO102.99%

Recent News & Updates

Recent updates

Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Jan 31
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

Jan 04
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

Dec 07
We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

Shareholder Returns

4169TW BiotechsTW Market
7D-1.0%-2.6%-2.1%
1Y0.9%-0.8%25.6%

Return vs Industry: 4169 exceeded the TW Biotechs industry which returned -0.8% over the past year.

Return vs Market: 4169 underperformed the TW Market which returned 25.6% over the past year.

Price Volatility

Is 4169's price volatile compared to industry and market?
4169 volatility
4169 Average Weekly Movement1.5%
Biotechs Industry Average Movement4.5%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4169 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4169's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998n/aYa-Chun Wangwww.tcmbio.com

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company’s products include osteoarthritis treatment products, osteoporosis treatment preparations, iron supplement, urinary system treatment products, expectorants/mucolytic agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

TCM Biotech International Corp. Fundamentals Summary

How do TCM Biotech International's earnings and revenue compare to its market cap?
4169 fundamental statistics
Market capNT$3.44b
Earnings (TTM)NT$20.00m
Revenue (TTM)NT$834.32m

171.8x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4169 income statement (TTM)
RevenueNT$834.32m
Cost of RevenueNT$422.87m
Gross ProfitNT$411.45m
Other ExpensesNT$391.45m
EarningsNT$20.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.34
Gross Margin49.32%
Net Profit Margin2.40%
Debt/Equity Ratio10.2%

How did 4169 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

83%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 23:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TCM Biotech International Corp. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullKGI Securities Co. Ltd.
Hsuan ChenKGI Securities Co. Ltd.